VISTOGARD
NDC 50633-220, uridine triacetate, granule, from BTG International Inc.
- Product NDC
- 50633-220
- Status
- Listed
- Labeler
- BTG International Inc
- Dosage form
- GRANULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA208159
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50633-220 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- URIDINE TRIACETATE951 mg/g
Pharmacologic classes
Analogs/Derivatives [Chemical/Ingredient]; Pyrimidine Analog [EPC]; Pyrimidines [Chemical/Ingredient]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50633-220-04 | 50633022004 | 4 PACKET in 1 CARTON (50633-220-04) / 10 g in 1 PACKET (50633-220-10) |
| 50633-220-20 | 50633022020 | 20 PACKET in 1 CARTON (50633-220-20) / 10 g in 1 PACKET (50633-220-10) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/269f7363-63ed-444e-85f1-f0009e44818b
Use it
Look up 50633-220 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50633-220 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50633-220. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.